Search

MannKind Corp

Closed

SectorHealthcare

4.06 -0.49

Overview

Share price change

24h

Current

Min

4.01

Max

4.19

Key metrics

By Trading Economics

Income

-671K

-17M

Sales

-22M

90M

P/E

Sector Avg

140.5

60.149

EPS

-0.02

Profit margin

-18.431

Employees

591

EBITDA

5M

2.5M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+99.27% upside

Dividends

By Acuity

Next Earnings

5 sie 2026

Market Stats

By TradingEconomics

Market Cap

396M

1.3B

Previous open

4.55

Previous close

4.06

News Sentiment

By Acuity

50%

50%

159 / 342 Ranking in Healthcare

MannKind Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

16 lip 2026, 23:52 UTC

Social Media
News

Netflix Inc. shares fell in after-hours trading following Q2 results. Revenue of $12.56 billion missed expectations, and guidance for 2026 was narrowed lower.

16 lip 2026, 23:46 UTC

News

Paychex declared a quarterly dividend of $1.19 per share, payable August 28, contributing to positive sentiment as shares rise in after-market trading.

16 lip 2026, 23:46 UTC

ETF Constituents
News
Correlated Moves

Vanguard Growth ETF declines after-hours, impacted by Netflix's drop and broader Nasdaq 100 downturn amid rising inflation concerns and central bank comments.

16 lip 2026, 23:41 UTC

News
Correlated Moves

Lam Research Corp shares are lower in after-market trading amid a sector-wide selloff following TSMC's capital expenditure announcement and bearish sentiment from options traders.

16 lip 2026, 23:36 UTC

News

T-Mobile US Inc. experienced routine after-market trading with little change since Thursday's close, maintaining its focus on versatile mobile internet plans.

16 lip 2026, 23:31 UTC

News
Correlated Moves

Micron Technology shares declined in after-market trading amid negative sentiment in the tech sector and concerns over rising capital costs from TSMC.

16 lip 2026, 23:21 UTC

News
Social Media

PayPal Holdings Inc. shares are lower in after-market hours as its board deems a $53 billion takeover bid from Stripe inadequate amid broader market declines.

16 lip 2026, 23:16 UTC

Correlated Moves
News

Intuit Inc shares are lower in after-market trading following a class action lawsuit alleging overstated revenue growth and competitive advantages. Concerns about layoffs persist.

16 lip 2026, 23:16 UTC

News
Social Media

Alphabet Inc shares are higher in after-market trading, rebounding from earlier session lows. Concerns persist over delays in the rollout of its Gemini AI.

16 lip 2026, 23:06 UTC

News

United Airlines Holdings Inc shares are lower in after-market hours, reflecting broader market declines amid concerns over major tech stocks and geopolitical risks.

16 lip 2026, 23:02 UTC

News
Social Media

Intuitive Surgical shares fell in after-market trading despite strong earnings, as management cited U.S. market challenges and a Class II recall of surgical components.

16 lip 2026, 23:01 UTC

News

Escalating military tensions in the Middle East are impacting the United States Oil Fund LP, which is trading lower during after-market hours.

16 lip 2026, 23:01 UTC

News
ETF Constituents
Correlated Moves
Macro News

Vanguard Information Technology ETF declines after major indices drop, led by weakness in semiconductor stocks and a significant decline in Netflix shares.

16 lip 2026, 23:01 UTC

News

Fiserv Inc. shares are lower in after-market trading amid operational challenges, including a 2% revenue decline and a significant drop in operating income.

16 lip 2026, 20:07 UTC

News

Spot silver prices are higher today, despite earlier pulling back from a session high, amid escalating U.S.-Iran tensions and rising inflation concerns.

16 lip 2026, 20:07 UTC

News
Correlated Moves

CHF/HKD is trading lower as initial jobless claims fall to a two-month low, indicating labor market strength amid rising geopolitical tensions.

16 lip 2026, 20:06 UTC

News
Correlated Moves

Gold prices are lower as inflation risks rise amid the U.S.-Iran conflict. Earlier, gold peaked at $3,992.10 per ounce before declining.

16 lip 2026, 20:06 UTC

News
Correlated Moves

Spot silver prices are declining amid rising U.S.-Iran tensions and inflation concerns, currently trading around $56.82 per ounce. Gold also fell sharply today.

16 lip 2026, 20:06 UTC

Macro Event
Correlated Moves
News

Xcel Energy shares are higher, supported by analysts' positive ratings adjustments and a favorable move in the Electric Utilities sub-sector.

16 lip 2026, 20:06 UTC

Correlated Moves
News

Spot silver prices are lower today, trading around $56.82 per ounce amid rising inflation concerns and expectations for Federal Reserve rate hikes.

16 lip 2026, 20:06 UTC

News
Correlated Moves

Spot silver prices are declining amid rising U.S.-Iran tensions and inflation concerns. The metal is trading near $56.82 per ounce, reflecting broader weakness in precious metals.

16 lip 2026, 20:06 UTC

News
Correlated Moves

Spot silver prices are declining amid rising U.S.-Iran tensions and inflation concerns, trading around $56.82 per ounce after a significant drop since Wednesday.

16 lip 2026, 20:06 UTC

Correlated Moves
News

Spot silver prices are lower, trading around $56.82 per ounce amid rising U.S.-Iran tensions and inflation concerns. Gold also declined significantly today.

16 lip 2026, 20:06 UTC

Correlated Moves
News

Spot silver prices are lower today, trading around $56.82 per ounce amid rising inflation concerns and expectations for Federal Reserve rate hikes.

16 lip 2026, 20:06 UTC

Correlated Moves
News

GBP/HKD is trading lower amid the Bank of Korea's interest rate hike to 2.75%. The currency pair reached a session low following early gains.

16 lip 2026, 20:03 UTC

Correlated Moves
News

Wedbush initiated coverage on Verisign with an Outperform rating. Shares are gaining today, reflecting positive sentiment after closing at $268.85.

16 lip 2026, 20:03 UTC

News

O'Reilly Automotive advances amid speculation of a $10 billion acquisition of Genuine Parts' auto parts unit, with analysts citing potential benefits despite FTC review concerns.

16 lip 2026, 20:03 UTC

Correlated Moves
Social Media
News

Qualcomm Inc shares are lower as the semiconductor sector faces pressure from Micron Technology's supply agreements and a notable decline in the Nasdaq 100 Index.

16 lip 2026, 20:02 UTC

News

Align Technology Inc. reported first-quarter revenue of $1.00 billion, slightly above expectations, but shares are lower amid broader market unease and geopolitical tensions.

16 lip 2026, 19:56 UTC

News
Social Media

Expedia Group shares rise after Wedbush initiated coverage with an Outperform rating and a price target of $334, indicating growth potential.

Peer Comparison

Price change

MannKind Corp Forecast

Price Target

By TipRanks

99.27% upside

12 Months Forecast

Average 8.15 USD  99.27%

High 11 USD

Low 4.75 USD

Based on 6 Wall Street analysts offering 12 month price targets forMannKind Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

5

Buy

1

Hold

0

Sell

Sentiment

By Acuity

159 / 342 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About MannKind Corp

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults. The company's product pipeline also includes Tyvaso DPI (Treprostinil), an inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; MNKD-101, a nebulized formulation of clofazimine, for the treatment of severe chronic and recurrent pulmonary infections, including nontuberculous mycobacterial lung disease; MNKD-201, a dry-powder formulation of nintedanib, for the treatment of idiopathic pulmonary fibrosis (IPF). In addition, it has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; co-promotion agreement with Vertice Pharma to promote Thyquidity; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. Further, the company has supply and distribution agreement with Biomm S.A. for the commercialization of Afrezza in Brazil; and license and distribution agreement with Cipla Ltd. for the marketing and distribution of Afrezza in India. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.
help-icon Live chat